Rafaella Keila Moreira Paixão

Rafaella Keila Moreira Paixão

Auto-generated profile, based on publicly available information

Rafaella Keila Moreira Paixão

Universidade Ceuma

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in E-Acadêmica
Verified
Journal Article
Open access
PDF file
JPJoão Victor Carvalho da Paz
João Victor Carvalho da Paz
SSSolano Kaluangila Andrelino Santiago
Solano Kaluangila Andrelino Santiago
TGThamires Mendes Gomes
Thamires Mendes Gomes
JSJohana Mirela Shikama Silveira
Johana Mirela Shikama Silveira
LRLetícia Chaves Véras Do Rosário
Letícia Chaves Véras Do Rosário
LFLucas Freire Fialho
Lucas Freire Fialho
Progressive Multifocal Leukoencephalopathy (PML) is a neurological condition caused by the JC virus, predominantly impacting the central nervous system. Its aggressiveness is evident in patients with immunological compromise, such as those with HIV/AIDS, transplants or those undergoing specific therapies. The objective of this work is to analyze what the most recent literature presents on this topic, considering its relevance today. In this way, we intend to bring to light topics that can improve the life expectancy of these patients." A systematic and quantitative review of the literature was conducted, using platforms such as PubMed, SciELO and Google Scholar until 2023. Exclusion criteria were applied to select retrospective or prospective non-randomized studies for inclusion in the meta-analysis. When the JC virus is reanimated in immunosuppressed hosts, it plays a very important role in the development of PML. Its spectrum of manifestations ranges from demyelination to focal neurological deficits, detectable through examinations imaging techniques such as CT and MRI. Despite efforts, an effective treatment for PML has not yet been identified. Current strategies aim to strengthen the adaptive immune response, such as immediate initiation of antiretroviral therapy in patients with HIV. Research is exploring therapies involving HIV vaccines. dendritic cells and other approaches, but more research is needed. PML remains deadly in most cases. Early detection and a multidisciplinary approach are key to management. Healthcare professionals must be vigilant regarding neurological symptoms in immunosuppressed patients, while awareness and regular monitoring are crucial for patients.

14 May 2022 in E-Acadêmica
Verified
Journal Article
Open access
PDF file
JPJoão Victor Carvalho Paz
João Victor Carvalho Paz
AAAlexandre Augusto Gomes Alves
Alexandre Augusto Gomes Alves
BABeatriz da Cruz Alves
Beatriz da Cruz Alves
LBLucas Frota Beckman
Lucas Frota Beckman
DADanielle Cavalcante Cruz Almeida
Danielle Cavalcante Cruz Almeida
RPRafaella Keila Moreira Paixão
Rafaella Keila Moreira Paixão
Introduction: Pituitary apoplexy is a potentially fatal disorder due to acute ischemic infarction or hemorrhage of the pituitary gland. The main clinical features of this syndrome are headache, nausea, vomiting, visual impairment, altered mental status and even coma. Methodology: This is a systematic literature review of the quantitative type using the following Keywords: Adeno-Pituitary; Pituitary Apoplexy; Pituitary Neoplasms; Review of Reported Cases. Result: As the primary event involves the adenoma, the syndrome should be termed pituitary tumor apoplexy and not pituitary apoplexy. Although pituitary apoplexy occurs within pituitary adenomas, it can also occur in non-adenomatous or even normal pituitary, especially during pregnancy. Discussion: Although the terminology "subclinical pituitary apoplexy" is widely used to describe anatomopathological evidence of asymptomatic pituitary ischemia or hemorrhage, it is significant to note that pituitary apoplexy is a clinical syndrome and not an anatomopathological definition. Conclusion: although pituitary apoplexy is an uncommon complication of pituitary tumors, it must be recognized as a neuroendocrinological and neurosurgical emergency that requires immediate diagnosis and treatment, individualizing each individual to direct to conservative or more invasive therapies.